VISTEON CORP
VCNASDAQ🏆 #1970 by market capEarnings Feb 17 · PostUS Equity
$72.41▼ $1.31 (−1.78%)
Market closed · at closeTrack VC
Get earnings, price moves & breaking news on Telegram
24h▼ 1.8%
7d▼ 11.4%
14d▼ 18.4%
30d▼ 16.8%
ytd▼ 23.8%
1y▼ 30.5%
🏦Market Cap
$1.79B
Small Cap
📈Revenue Growth (YoY)
-2.5%
Declining
📊Gross Margin
10.4%
Thin
💵FCF Margin
1.3%
Thin
⚖️P/S Ratio
0.5x
Cheap
Otter Score
56
Fair
VISTEON CORP
VCAnalyst Ratings
Price
$72.41
Total
23
Raised
2
Lowered
6
Avg PT
$111.88
H / L
$132 / $95
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Overweight | 2026-10-28 | $105.00 | +45.00% |
TD Cowen | Reiterated | Buy | 2026-10-23 | — | — |
UBS | Reiterated | Buy | 2026-10-23 | $96.00 | +32.60% |
JP Morgan | Reiterated | Overweight | 2026-10-23 | — | — |
RBC Capital | Reiterated | Outperform | 2026-10-23 | $130.00 | +79.50% |
Goldman Sachs | Reiterated | Buy | 2026-10-06 | $103.00 | +42.30% |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2026-07-28 | $135.00 | +86.50% |
Wells Fargo | Reiterated | Overweight | 2026-07-24 | $145.00 | +100.30% |
Deutsche Bank | Reiterated | Buy | 2026-07-09 | $132.00 | +82.30% |
Baird | Downgraded | Outperform → Neutral | 2026-06-26 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-06-26 | $130.00 | +79.50% |
B of A Securities | Reiterated | Buy | 2025-09-10 | — | — |
Guggenheim | Reiterated | Buy | 2025-09-09 | $143.00 | +97.50% |
Citigroup | Reiterated | Buy | 2024-07-12 | $145.00 | +100.30% |
Exane BNP Paribas | Downgraded | Outperform → Neutral | 2023-12-13 | — | — |
Jefferies | Reiterated | Buy | 2022-02-18 | — | — |
B. Riley FBR | Downgraded | Buy → Neutral | 2019-04-26 | — | — |
B. Riley Securities | Downgraded | Buy → Neutral | 2019-04-26 | — | — |
BMO Capital | Reiterated | Outperform | 2019-02-25 | — | — |
Gabelli & Co. | Upgraded | Hold → Buy | 2018-02-26 | — | — |
Raymond James | Upgraded | Market Perform → Outperform | 2017-01-11 | — | — |
Tigress Financial | Downgraded | Buy → Neutral | 2016-05-18 | — | — |
Susquehanna | Reiterated | Positive | 2015-07-17 | — | — |
Institution
Barclays
Reiterated · Overweight · 2026-10-28
$105.00
+45.00%
TD Cowen
Reiterated · Buy · 2026-10-23
—
—
UBS
Reiterated · Buy · 2026-10-23
$96.00
+32.60%
JP Morgan
Reiterated · Overweight · 2026-10-23
—
—
RBC Capital
Reiterated · Outperform · 2026-10-23
$130.00
+79.50%
Goldman Sachs
Reiterated · Buy · 2026-10-06
$103.00
+42.30%
Wolfe Research
Downgraded · Outperform → Peer Perform · 2026-07-28
$135.00
+86.50%
Wells Fargo
Reiterated · Overweight · 2026-07-24
$145.00
+100.30%
Deutsche Bank
Reiterated · Buy · 2026-07-09
$132.00
+82.30%
Baird
Downgraded · Outperform → Neutral · 2026-06-26
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-06-26
$130.00
+79.50%
B of A Securities
Reiterated · Buy · 2025-09-10
—
—
Guggenheim
Reiterated · Buy · 2025-09-09
$143.00
+97.50%
Citigroup
Reiterated · Buy · 2024-07-12
$145.00
+100.30%
Exane BNP Paribas
Downgraded · Outperform → Neutral · 2023-12-13
—
—
Jefferies
Reiterated · Buy · 2022-02-18
—
—
B. Riley FBR
Downgraded · Buy → Neutral · 2019-04-26
—
—
B. Riley Securities
Downgraded · Buy → Neutral · 2019-04-26
—
—
BMO Capital
Reiterated · Outperform · 2019-02-25
—
—
Gabelli & Co.
Upgraded · Hold → Buy · 2018-02-26
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2017-01-11
—
—
Tigress Financial
Downgraded · Buy → Neutral · 2016-05-18
—
—
Susquehanna
Reiterated · Positive · 2015-07-17
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space